Arsenic trioxide in front-line therapy of acute promyelocytic leukemia (C9710): prognostic significance of FLT3 mutations and complex karyotype

The addition of arsenic trioxide (ATO) to frontline therapy of acute promyelocytic leukemia (APL) has been shown to result in significant improvements in disease-free survival (DFS). FLT3 mutations are frequently observed in APL, but its prognostic significance remains unclear. We analyzed 245 newly...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Leuk Lymphoma
Main Authors: Poiré, Xavier, Moser, Barry K., Gallagher, Robert E., Laumann, Kristina, Bloomfield, Clara D., Powell, Bayard L., Koval, Gregory, Gulati, Kabir, Holowka, Nicholas, Larson, Richard A., Tallman, Martin S., Appelbaum, Frederick R., Sher, Dorie, Willman, Cheryl, Paietta, Elisabeth, Stock, Wendy
Formato: Artigo
Idioma:Inglês
Publicado: 2014
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4273565/
https://ncbi.nlm.nih.gov/pubmed/24160850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2013.842985
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares